Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Common Hormone Therapies Used to Care for Transgender Patients Influence Laboratory Results.

Humble RM, Imborek KL, Nisly N, Greene DN, Krasowski MD.

J Appl Lab Med. 2019 Mar;3(5):799-814. doi: 10.1373/jalm.2018.027078. Epub 2018 Sep 27.

PMID:
31639755
2.

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults.

Beckwith N, Reisner SL, Zaslow S, Mayer KH, Keuroghlian AS.

Transgend Health. 2017 Oct 1;2(1):156-164. doi: 10.1089/trgh.2017.0028. eCollection 2017.

3.

Hematology reference intervals for transgender adults on stable hormone therapy.

Greene DN, McPherson GW, Rongitsch J, Imborek KL, Schmidt RL, Humble RM, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD.

Clin Chim Acta. 2019 May;492:84-90. doi: 10.1016/j.cca.2019.02.011. Epub 2019 Feb 13.

PMID:
30771301
4.

Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.

Olson-Kennedy J, Chan YM, Garofalo R, Spack N, Chen D, Clark L, Ehrensaft D, Hidalgo M, Tishelman A, Rosenthal S.

JMIR Res Protoc. 2019 Jul 9;8(7):e14434. doi: 10.2196/14434.

5.

Gender affirming medical care of transgender youth.

Salas-Humara C, Sequeira GM, Rossi W, Dhar P.

Curr Probl Pediatr Adolesc Health Care. 2019 Nov 14:100683. doi: 10.1016/j.cppeds.2019.100683. [Epub ahead of print]

PMID:
31735692
6.

Hormone Therapy for Transgender Adults.

Radix A.

Urol Clin North Am. 2019 Nov;46(4):467-473. doi: 10.1016/j.ucl.2019.07.001. Epub 2019 Aug 19. Review.

PMID:
31582021
7.

When Gender Identity Doesn't Equal Sex Recorded at Birth: The Role of the Laboratory in Providing Effective Healthcare to the Transgender Community.

Goldstein Z, Corneil TA, Greene DN.

Clin Chem. 2017 Aug;63(8):1342-1352. doi: 10.1373/clinchem.2016.258780. Epub 2017 Jul 5. Review.

8.

Physiologic Response to Gender-Affirming Hormones Among Transgender Youth.

Olson-Kennedy J, Okonta V, Clark LF, Belzer M.

J Adolesc Health. 2018 Apr;62(4):397-401. doi: 10.1016/j.jadohealth.2017.08.005. Epub 2017 Oct 19.

PMID:
29056436
9.

Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report.

O'Bryan J, Wolf-Gould C, Matsuo Y.

Transgend Health. 2018 Jan 1;3(1):1-9. doi: 10.1089/trgh.2017.0026. eCollection 2018.

10.

Impact of Hormone Therapy on Laboratory Values in Transgender Patients.

SoRelle JA, Jiao R, Gao E, Veazey J, Frame I, Quinn AM, Day P, Pagels P, Gimpel N, Patel K.

Clin Chem. 2019 Jan;65(1):170-179. doi: 10.1373/clinchem.2018.292730. Epub 2018 Dec 5.

PMID:
30518663
11.

Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.

McFarlane T, Zajac JD, Cheung AS.

Clin Endocrinol (Oxf). 2018 Dec;89(6):700-711. doi: 10.1111/cen.13835. Epub 2018 Sep 18. Review.

PMID:
30107028
12.

Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.

Rowniak S, Bolt L, Sharifi C.

JBI Database System Rev Implement Rep. 2019 Sep;17(9):1826-1854. doi: 10.11124/JBISRIR-2017-003869.

PMID:
31021971
13.

Acute Clinical Care for Transgender Patients: A Review.

Rosendale N, Goldman S, Ortiz GM, Haber LA.

JAMA Intern Med. 2018 Nov 1;178(11):1535-1543. doi: 10.1001/jamainternmed.2018.4179. Review.

PMID:
30178031
14.

Masculinizing Genital Gender Confirmation Surgery.

Hadj-Moussa M, Agarwal S, Ohl DA, Kuzon WM Jr.

Sex Med Rev. 2019 Jan;7(1):141-155. doi: 10.1016/j.sxmr.2018.06.004. Epub 2018 Aug 16. Review.

PMID:
30122339
15.

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.

Connelly PJ, Marie Freel E, Perry C, Ewan J, Touyz RM, Currie G, Delles C.

Hypertension. 2019 Dec;74(6):1266-1274. doi: 10.1161/HYPERTENSIONAHA.119.13080. Epub 2019 Oct 28.

PMID:
31656099
16.

Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.

de Haan G, Santos GM, Arayasirikul S, Raymond HF.

LGBT Health. 2015 Dec;2(4):313-23. doi: 10.1089/lgbt.2014.0128. Epub 2015 Aug 31.

PMID:
26788772
17.

Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis.

Singh-Ospina N, Maraka S, Rodriguez-Gutierrez R, Davidge-Pitts C, Nippoldt TB, Prokop LJ, Murad MH.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3904-3913. doi: 10.1210/jc.2017-01642. Review.

PMID:
28945851
18.

Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people.

Quinn VP, Nash R, Hunkeler E, Contreras R, Cromwell L, Becerra-Culqui TA, Getahun D, Giammattei S, Lash TL, Millman A, Robinson B, Roblin D, Silverberg MJ, Slovis J, Tangpricha V, Tolsma D, Valentine C, Ward K, Winter S, Goodman M.

BMJ Open. 2017 Dec 27;7(12):e018121. doi: 10.1136/bmjopen-2017-018121.

19.

Clinical pearls of gender-affirming hormone therapy in transgender patients.

Irving A, Lehault WB.

Ment Health Clin. 2018 Mar 26;7(4):164-167. doi: 10.9740/mhc.2017.07.164. eCollection 2017 Jul.

20.

Assessment of Gender-Affirming Hormone Therapy Requirements.

Fernandez JD, Kendjorsky K, Narla A, Villasante-Tezanos AG, Tannock LR.

LGBT Health. 2019 Apr;6(3):101-106. doi: 10.1089/lgbt.2018.0116. Epub 2019 Feb 27.

Supplemental Content

Support Center